Filing Flows

Filing Flows › Companies › MDWerks › Cash flow

MDWerks cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$117K in Q2 2026 · −$1.6M over twelve months

Operating cash flow−$141K
Capital spending$25K
Free cash flow−$117K
Cash conversion cycle-181 days

Analysis

In Q2 2026, MDWerks generated −$141K of operating cash flow and spent −$25K on capital projects, leaving free cash flow of −$117K. That is $396K more than in Q2 2025 (−$513K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$1.3M; the largest uses were operating cash flow ($1.3M), capital spending ($203K); besides operations, cash came from other financing ($1.6M); the cash balance fell by $72.

Operating cash flow was −$141K against net income of −$530K. The largest differences: inventory +$131K, depreciation & amortization +$93K, receivables −$79K.

Its cash conversion cycle was -181 days (receivables 11 + inventory 127 − payables 319): suppliers fund its working capital.

Free cash flow

MDWerks: free cash flow by quarterMDWerks: free cash flow by quarter−$203KQ3 2024−$119KQ4 2024−$1.0MQ1 2025−$513KQ2 2025−$434KQ3 2025−$474KQ4 2025−$527KQ1 2026−$117KQ2 2026
Operating cash flow less capital spending.
MDWerks: operating cash flow against capital spendingMDWerks: operating cash flow against capital spendingOperating cash flowCapital spending−$204K−$2KQ3 2024−$119K$0Q4 2024−$421K$604KQ1 2025−$410K$103KQ2 2025−$363K$71KQ3 2025−$380K$94KQ4 2025−$464K$63KQ1 2026−$141K−$25KQ2 2026
Latest (Q2 2026): Operating cash flow −$141K, Capital spending −$25K.

Capital allocation, year by year

MDWerks: where the cash came from (up) and went (down), by fiscal yearMDWerks: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingFY2021: Operating cash flow −$20KFY2021FY2022: Operating cash flow −$120KFY2022: Net borrowing $114K$114KFY2022FY2023: Operating cash flow −$520KFY2023: Net borrowing −$104KFY2023: Asset sales $100KFY2023: Capital spending −$88K$100KFY2023FY2024: Operating cash flow −$782KFY2024: Net borrowing −$183KFY2024: Shares issued $745KFY2024: Capital spending −$7K$745KFY2024FY2025: Operating cash flow −$1.6MFY2025: Net borrowing $150KFY2025: Shares issued $2.9MFY2025: Capital spending −$872K$3.1MFY2025
Over these 5 years operating cash flow totalled −$3.0M; the largest uses were operating cash flow ($3.0M) and capital spending ($967K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$13K
Debt$541K
Net debt$528K
Due within a year$258K
Cash runway0 months

MDWerks is burning cash: its operations consume cash, a free cash flow of −$1.6M a year at the current rate against $13K of cash and investments: a runway of about 0 months; $258K of debt also comes due within a year, which would need refinancing or new money before any new financing.

MDWerks: debt maturities by year (FY2024)MDWerks: debt maturities by year (FY2024)$258KYear 1$87KYear 2$60KYear 3$51KYear 4
Principal due in each year as disclosed in the annual report, against $13K of cash and investments now.

Where the cash came from and went

MDWerks: sources (+) and uses (−) of cash, Q2 2026MDWerks: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$141KCash drawn (+) / kept (−)$82KOther financing$34KCapital spending$25K
MDWerks: sources (+) and uses (−) of cash, TTM to Q2 2026MDWerks: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$1.6MOperating cash flow−$1.3MCapital spending−$203KCash drawn (+) / kept (−)$72

From profit to cash

MDWerks: net income to operating cash flow, Q2 2026MDWerks: net income to operating cash flow, Q2 2026Net income−$530KDepreciation & amortization$93KStock-based pay$40KImpairments$71KReceivables−$79KInventory$131KDeferred revenue$53KPrepaid and other assets$24KOperating cash flow−$141K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202611127319-181
Q1 20267118246-121
Q4 202515104177-58
Q3 202511153221-58
Q2 2025171481596
Q1 202518158198-22
Q4 20244245169-82
Q3 20241148199-140

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$141K$25K——$82K−$117K
Q1 2026−$464K−$63K—$450K$116K−$527K
Q4 2025−$380K−$94K——−$31K−$474K
Q3 2025−$363K−$71K——−$168K−$434K
Q2 2025−$410K−$103K——$580K−$513K
Q1 2025−$421K−$604K—$50K−$582K−$1.0M
Q4 2024−$119K—−$40K—$51K−$119K
Q3 2024−$204K$2K−$53K—−$15K−$203K

MDWerks: income statement and cash flow

MDWerks, Q2 2026: revenue $524K (+25% year over year), operating margin -97.2%. The chart follows the revenue to costs, profit and cash.

MDWerks: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.